Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors
Clinical trial NCT01055795 · COMPLETED
Trial details
- NCT number
- NCT01055795
- Sponsor
- Herbert Hurwitz
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.